Just thought Id mention, Oncbiomune is working on a prostate cance vaccine. Getting ready to kick off phase II early stage at Harvard and late stage at North Texas UN. Phase 1 data was pretty good. Still a ways to go to prove it.

Kevetrin, with almost no side effects, that's a winner I can't wait to see get into the advanced trials.